打印 位置、旅行和住宿Mayo Clinic 在亚利桑那州的芬尼克斯和斯克茨戴尔、佛罗里达州的杰克逊威尔和明尼苏达州的罗切斯特都有主要校区。Mayo Clinic 健康系统在几个州拥有十几个工作地点。 有关参观 Mayo Clinic 的更多信息,请在下面选择您的位置: 妙佑医疗国际亚利桑那州院区 妙佑医疗国际佛罗里达州院区 妙佑医疗国际明尼苏达州院区 妙佑区域医疗系统 伦敦妙佑医疗中心 费用与保险妙佑医疗国际与数百家保险公司合作,是数百万人的网络内医疗服务提供者。 在大多数情况下,妙佑医疗国际不需要医生转诊。某些保险公司要求转诊,或有其他特定医疗要求。所有约诊的优先级都以医疗需求为基础。 详细了解在妙佑医疗国际约诊的信息。 请联系您的保险公司,核实承保范围,并在就医之前获得任何所需的授权。保险公司的客户服务号码通常印在保险卡背面。 有关账单和保险的更多信息: 妙佑医疗国际亚利桑那州、佛罗里达州以明尼苏达州院区 妙佑区域医疗系统 来自妙佑医疗国际员工 申请预约 关于 Sept. 05, 2026 打印显示参考文献 FDA approves sacituzumab govitecan-hziy as monotherapy and in combination with pembrolizumab for first-line treatment of triple-negative breast cancer. U.S. Food and Drug Administration. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-sacituzumab-govitecan-hziy-monotherapy-and-combination-pembrolizumab-first-line. Accessed Aug. 4, 2026. Immunotherapy for breast cancer. National Cancer Institute. https://www.cancer.gov/types/breast/treatment/immunotherapy. Accessed Aug. 4, 2026. Schmid P, et al. Overall survival with pembrolizumab in early-stage triple-negative breast cancer. New England Journal of Medicine. 2024; doi:10.1056/NEJMoa2409932. Heater NK, et al. Current and future immunotherapy for breast cancer. Journal of Hematology & Oncology. 2024; doi:10.1186/s13045-024-01649-z. Immune checkpoint inhibitors. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors. Accessed Aug. 4, 2026. Cortes J, et al. Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. New England Journal of Medicine. 2022; doi:10.1056/NEJMoa2202809. Raghavendra AS, et al. Breast cancer brain metastasis: A comprehensive review. JCO Oncology Practice. 2024; doi:10.1200/OP.23.00794. Villacampa G, et al. Neoadjuvant immune checkpoint inhibitors plus chemotherapy in early breast cancer: A systematic review and meta-analysis. JAMA Oncology. 2024; doi:10.1001/jamaoncol.2024.3456. Verma S, et al. Immunotherapy and radiation therapy sequencing in breast cancer: A systematic review. International Journal of Radiation Oncology, Biology, Physics. 2024; doi:10.1016/j.ijrobp.2024.01.001. Madsen AMH, et al. Targeted treatment of metastatic triple-negative breast cancer: A systematic review. The Breast Journal. 2024; doi:10.1155/2024/9083055. Chemotherapy for breast cancer. National Cancer Institute. https://www.cancer.gov/types/breast/treatment/chemotherapy. Accessed Aug. 5, 2026. Medical review (expert opinion). Mayo Clinic. Sept. 2, 2026. 相关 乳腺癌 Immunotherapy for breast cancer关于在 Mayo Clinic 治疗 PRC-20605578 医学检查与医疗程序 Breast cancer immunotherapy